To Evaluate the Pharmacokinetics of Hemay005 Tablets in Subjects With Liver Damage

PHASE1RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 28, 2024

Primary Completion Date

December 10, 2025

Study Completion Date

December 31, 2025

Conditions

Psoriasis

Interventions

DRUG

Hemay005

15mg/tablet，Four tablets (60mg) each time. Participants will receive a single dose of Hemay005 tablet in Day1

Trial Locations (1)

RECRUITING

Union Hospital of Tongji Medical College; Huazhong University of Science and Technology, Wuhan